26 July 2024
FDA Advisory Committee reviewed Imfinzi for treatment of resectable non-small cell lung cancer based on AEGEAN Phase III trial results The Food and Drug Administration’s (FDA)…
25 July 2024
HICL Infrastructure PLC “HICL” or “the Company” and, together with its subsidiaries, “the Group”, the London-listed infrastructure investment company managed by InfraRed Capital Partners Limited…
RELX, the global provider of information-based analytics and decision tools, reports results for the first half of 2024 and reaffirms the full year outlook….
YOUNG & CO.’S BREWERY, P.L.C. (“Young’s”) AGM Update Young’s, the premium operator of pubs and bedrooms, will host its Annual General Meeting at 11.30am…
H1 and Q2 2024 results Strong underlying growth supports FY 2024 guidance upgrade, with both Total Revenue and Core EPS now expected to increase…
“In the first six months of 2024, the Group delivered robust financial results with solid income performance and cost discipline alongside strong capital generation….
2024 First Half Results Innovation and brand investment driving faster volume growth Underlying performance GAAP measures (unaudited) 2024 vs 2023…
24 July 2024
M. P. EVANS GROUP PLC (“THE GROUP”)2024 H1 crop and production M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is pleased to…